Phathom Pharmaceuticals (PHAT) Payables: 2022-2025
Historic Payables for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Sep 2025 value amounting to $1.1 million.
- Phathom Pharmaceuticals' Payables fell 84.93% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.2 million, marking a year-over-year decrease of 23.99%. This contributed to the annual value of $10.5 million for FY2024, which is 16.62% down from last year.
- Latest data reveals that Phathom Pharmaceuticals reported Payables of $1.1 million as of Q3 2025, which was down 73.18% from $4.0 million recorded in Q2 2025.
- Phathom Pharmaceuticals' Payables' 5-year high stood at $12.6 million during Q4 2023, with a 5-year trough of $1.1 million in Q3 2025.
- Its 3-year average for Payables is $7.1 million, with a median of $7.1 million in 2024.
- Its Payables has fluctuated over the past 5 years, first skyrocketed by 83.42% in 2024, then crashed by 84.93% in 2025.
- Over the past 4 years, Phathom Pharmaceuticals' Payables (Quarterly) stood at $10.0 million in 2022, then rose by 26.05% to $12.6 million in 2023, then declined by 16.62% to $10.5 million in 2024, then slumped by 84.93% to $1.1 million in 2025.
- Its Payables was $1.1 million in Q3 2025, compared to $4.0 million in Q2 2025 and $11.6 million in Q1 2025.